MAX
Autonomix Medical, Inc.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
-0.0565 | 33.29 | -100.17% | -0.13 | -56.73% |
| P/S |
|
0 | 129.32 | -100% |
|
|
| P/BV |
|
0.0796 | 254.5 | -99.97% |
|
|
| P/FCF |
|
-0.078 | -175.34 | -99.96% |
|
|
| Ev/Ebitda |
|
0.55 | -27.64 | -101.98% |
|
|
| Ev/S |
|
0 | 535.9 | -100% |
|
|
| Ev/FCF |
|
0.73 | -282.58 | -100.26% |
|
|
| E/P |
|
-17.69 | 0.0225 | -78884.41% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
0 | -367.1 | -100% | 0 | 0% |
| ROE |
|
-140.88 | 104.5 | -234.81% |
|
|
| ROA |
|
-116.36 | -2.18 | 5246.93% |
|
|
| ROIC |
|
0 | 1.04 | -100% |
|
|
| ROS |
|
0 | -291.93 | -100% |
|
|
| ROCE |
|
-138.71 | 3.45 | -4115.86% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-0.0907 | 1.1 | -108.28% | -0.0823 | +10.14% |
| Nеt Debt/Ebitda |
|
0.83 | 1.17 | -29.35% |
|
|
| Debt/Ratio |
|
0.1 | 0.19 | -46.97% |
|
|
| Debt/Equity |
|
0.21 | 1.61 | -86.9% |
|
|
| Debt/Net Income |
|
-0.0878 | -1.32 | -93.34% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.54 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0.98 | -100% | ||
| DSI |
|
0 | 0.23 | -100% |
|
|
| Average dividend growth |
|
0 | 4 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 0.5 | -100% |
|
|
| Average percentage for payments |
|
0 | 57.47 | -100% |
|
|
| Difference from average difference in sector |
|
-0.54 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
0/10
|
0 | -54.61 | -100% | ||
| Growth impulse Ebitda in 5 years |
|
-1568.67 | -92 | 1605.08% | ||
| Growth impulse Net Income in 5 years |
|
-14.4 | -77.77 | -81.48% | ||
| Growth impulse FCF in 5 years |
|
2035.77 | -88.99 | -2387.64% | ||
| Growth impulse EPS in 5 years |
|
811.01 | -28.04 | -2992.33% |
IP Score
3.76/10
